AQB Reaps A Bounty, CLSN Ends Dual Listing, MNK Opens Wallet, OMER On Watch

Today's Daily Dose brings you news Celsion's decision to end dual listing; MiMedx's progress with AmnioFix Injectable; AquaBounty's improving Q2 financial results; tentative approval from FDA for Perrigo's generic version of rosacea treatment Mirvaso and Mallinckrodt's acquisition of privately-held InfaCare.

from RTT - Biotech http://ift.tt/2uhIcbB
via IFTTT